Researchers at IIT Bombay develop a shockwave-based needle-free syringe that ensures painless and safe drug delivery with lesser damage to skin and lower risk of infection
Human Mesenchymal Stem Cells found to favour the survival of tuberculosis bacteria, instead of fighting it, shows a recent study.
In a recent study, researchers at the Indian Institute of Science (IISc), Bengaluru, and Christian Medical College, Vellore, have developed a novel, inexpensive and easy-to-use device to detect tuberculosis.
Researchers find familial dissimilarities in proteins from two species of Mycobacterium.
In 2018, around 1.5 million people died from tuberculosis (TB) — an infectious disease that mainly affects the lungs. A major obstacle in the clinical treatment of TB is the long therapy time required to clear the infection. An infected patient needs to take antibiotics for over 6 to 9 months to prevent a relapse — a duration so long that many discontinue their medications.